Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Treasury Shares: 2024-2025

Historic Treasury Shares for Pyxis Oncology (PYXS) over the last 2 years, with Sep 2025 value amounting to $1.8 million.

  • Pyxis Oncology's Treasury Shares fell 39.74% to $1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 million, marking a year-over-year decrease of 39.74%. This contributed to the annual value of $2.5 million for FY2024, which is N/A change from last year.
  • Latest data reveals that Pyxis Oncology reported Treasury Shares of $1.8 million as of Q3 2025, which was down 7.33% from $1.9 million recorded in Q2 2025.
  • Over the past 5 years, Pyxis Oncology's Treasury Shares peaked at $3.1 million during Q1 2024, and registered a low of $1.8 million during Q3 2025.
  • Moreover, its 2-year median value for Treasury Shares was $2.5 million (2024), whereas its average is $2.5 million.
  • Data for Pyxis Oncology's Treasury Shares shows a maximum YoY crashed of 39.74% (in 2025) over the last 5 years.
  • Quarterly analysis of 2 years shows Pyxis Oncology's Treasury Shares stood at $2.5 million in 2024, then crashed by 39.74% to $1.8 million in 2025.
  • Its last three reported values are $1.8 million in Q3 2025, $1.9 million for Q2 2025, and $2.4 million during Q1 2025.